DRD5 Antikörper (C-Term)
Kurzübersicht für DRD5 Antikörper (C-Term) (ABIN363248)
Target
Alle DRD5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Reacts with rat D(1B) dopamine receptor
-
Kreuzreaktivität (Details)
- Do not react with human protein. Not tested in other species.
-
Aufreinigung
- Purified (protein A)
-
Immunogen
- Recombinant rat D1 (D1B) dopamine receptor (within the last 118 of the C-terminus)
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
- WB : 2 μg/mL -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Tris-glycine, NaCl 150 mM buffer, Sodium azide 0.05 %
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C/-80 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
-
- DRD5 (Dopamine Receptor D5 (DRD5))
-
Andere Bezeichnung
- Dopamine D5 Receptor
-
Pathways
- Regulation of Systemic Arterial Blood Pressure by Hormones, cAMP Metabolic Process, Regulation of long-term Neuronal Synaptic Plasticity
Target
-